Literature DB >> 30557715

Drugs of porcine origin-A risk for patients with α-gal syndrome?

Kyra Swiontek1, Martine Morisset2, Françoise Codreanu-Morel2, Jörg Fischer3, Jana Mehlich4, Ulf Darsow4, Nadine Petitpain5, Tilo Biedermann4, Markus Ollert6, Bernadette Eberlein4, Christiane Hilger7.   

Abstract

Entities:  

Year:  2018        PMID： 30557715     DOI： 10.1016/j.jaip.2018.12.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  6 in total

Review 1.  Diagnosis and Management of Patients with the α-Gal Syndrome.

Authors:  Thomas A E Platts-Mills; Rung-Chi Li; Behnam Keshavarz; Anna R Smith; Jeffrey M Wilson
Journal:  J Allergy Clin Immunol Pract       Date:  2019-09-28

2.  Tolerance of porcine pancreatic enzymes despite positive skin testing in alpha-gal allergy.

Authors:  Cosby A Stone; Shailesh Choudhary; Megan F Patterson; Christine R F Rukasin; David T Coleman; Elizabeth J Phillips; Scott P Commins
Journal:  J Allergy Clin Immunol Pract       Date:  2019-12-14

3.  On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.

Authors:  Thomas A E Platts-Mills; Scott P Commins; Tilo Biedermann; Marianne van Hage; Michael Levin; Lisa A Beck; Maria Diuk-Wasser; Uta Jappe; Danijela Apostolovic; Michael Minnicozzi; Marshall Plaut; Jeffrey M Wilson
Journal:  J Allergy Clin Immunol       Date:  2020-02-10       Impact factor: 10.793

Review 4.  Role and Mechanism of Galactose-Alpha-1,3-Galactose in the Elicitation of Delayed Anaphylactic Reactions to Red Meat.

Authors:  Christiane Hilger; Jörg Fischer; Florian Wölbing; Tilo Biedermann
Journal:  Curr Allergy Asthma Rep       Date:  2019-01-23       Impact factor: 4.806

5.  ENDURAGen graft durability in α-Gal disease.

Authors:  Kelly L Ruland; Maria Kirzhner
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-30

Review 6.  [Alpha-gal syndrome : Overview of clinical presentation and pathophysiology].

Authors:  J Fischer; T Reepschläger; T Schricker; U Raap
Journal:  Hautarzt       Date:  2022-02-04       Impact factor: 0.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.